Compare COMBAT DRUGS with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs VAISHALI PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DECIPHER LABS VAISHALI PHARMA DECIPHER LABS/
VAISHALI PHARMA
 
P/E (TTM) x 28.9 16.1 179.4% View Chart
P/BV x 6.5 1.8 363.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DECIPHER LABS   VAISHALI PHARMA
EQUITY SHARE DATA
    DECIPHER LABS
Mar-21
VAISHALI PHARMA
Mar-21
DECIPHER LABS/
VAISHALI PHARMA
5-Yr Chart
Click to enlarge
High Rs41NA-   
Low Rs18NA-   
Sales per share (Unadj.) Rs55.051.0 107.9%  
Earnings per share (Unadj.) Rs1.41.0 140.1%  
Cash flow per share (Unadj.) Rs2.21.4 157.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %0NM- 
Book value per share (Unadj.) Rs13.621.3 63.8%  
Shares outstanding (eoy) m10.1010.55 95.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.50-   
Avg P/E ratio x21.30-  
P/CF ratio (eoy) x13.40-  
Price / Book Value ratio x2.20-  
Dividend payout %00-   
Avg Mkt Cap Rs m2980-   
No. of employees `000NANA-   
Total wages/salary Rs m47312 3,984.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m556538 103.3%  
Other income Rs m618 35.7%   
Total revenues Rs m562556 101.1%   
Gross profit Rs m3526 131.6%  
Depreciation Rs m84 191.8%   
Interest Rs m1226 44.6%   
Profit before tax Rs m2114 152.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m74 206.7%   
Profit after tax Rs m1410 134.1%  
Gross profit margin %6.34.9 127.4%  
Effective tax rate %34.525.5 135.5%   
Net profit margin %2.51.9 129.7%  
BALANCE SHEET DATA
Current assets Rs m225813 27.7%   
Current liabilities Rs m173593 29.2%   
Net working cap to sales %9.441.0 23.0%  
Current ratio x1.31.4 94.9%  
Inventory Days Days7723 331.0%  
Debtors Days Days766452,945,946 0.0%  
Net fixed assets Rs m16147 344.4%   
Share capital Rs m101105 95.8%   
"Free" reserves Rs m36119 30.2%   
Net worth Rs m137224 61.1%   
Long term debt Rs m6740 166.5%   
Total assets Rs m387860 45.0%  
Interest coverage x2.81.5 184.5%   
Debt to equity ratio x0.50.2 272.6%  
Sales to assets ratio x1.40.6 229.8%   
Return on assets %6.74.3 155.8%  
Return on equity %10.24.7 219.6%  
Return on capital %16.215.2 106.6%  
Exports to sales %016.7 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA90 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m090 0.0%   
Fx outflow Rs m00 0.0%   
Net fx Rs m090 0.0%   
CASH FLOW
From Operations Rs m1820 91.1%  
From Investments Rs m-3-1 285.5%  
From Financial Activity Rs m40-18 -220.1%  
Net Cashflow Rs m551 6,187.6%  

Share Holding

Indian Promoters % 0.0 56.3 -  
Foreign collaborators % 45.9 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 54.1 43.7 123.7%  
Shareholders   12,796 10,822 118.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DECIPHER LABS With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Plunges 656 Points, Nifty Ends Below 18,000; Oil & Gas, Metal Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DECIPHER LABS SHARE PRICE


Jan 19, 2022 (Close)

TRACK DECIPHER LABS

  • Track your investment in DECIPHER LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DECIPHER LABS 5-YR ANALYSIS

COMPARE DECIPHER LABS WITH

MARKET STATS